TET1 and breast cancer: Overall, these results demonstrated that miR-27a-3p binds to TET1 and downregulates TET1 to activate EMT by promoting DNA methylation of ADCY6, thus promoting proliferation, migration and invasion of breast cancer cells (Figure 9E).